Respiratory and Lung
Research Group Head Professor Philip Bardin
The Respiratory and Lung Research group has ongoing research in both basic and clinical science. A key aim is to translate the group’s findings from the laboratory to patients, as well as taking patient problems to inform laboratory-based research. The group welcome both basic scientists and clinicians with an interest in lung disease to work in the group.
Laboratory research projects
- TGF-Beta laboratory studies using in vitro and murine studies.
- Effects of steroids in asthma/ chronic obstructive pulmonary disease (COPD). These studies examine new treatments for asthma/ COPD in mouse models.
- Human metapneumovirus (hMPV) studies in vitro. This is an important new virus and these studies examine its activity in asthma and COPD models.
- Extracellular traps in health and disease (with A/Prof Paul King).
Clinical research projects
- COPD studies focus on exacerbations, diagnostic imaging, cardiac morbidities, new treatments and rehabilitation.
- Asthma studies evaluate severe asthma, vocal cord dysfunction and new treatments.
- Lung infection studies are focused on disease mechanisms in bronchiectasis, cystic fibrosis, COPD and pneumonia.
Diseases we research
Research Group Head | Professor Philip Bardin
Obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) affect more than a third of all Australians. Acute flares, caused by virus infections, often result in disability and sometimes death. My research aims to prevent this by enhancing immunity and designing new treatments.